JG
LGND icon

Jefferies Group’s Ligand Pharmaceuticals LGND Stock Holding History

Jefferies Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37,621
Closed -$3.08M – 1879
2021
Q2 		$3.08M Buy
+37,621
New +$3.13M 0.02% 606
2020
Q4 		– Sell
-4,565
Closed -$271K – 1690
2020
Q3 		$271K Buy
+4,565
New +$311K ﹤0.01% 1118
2019
Q2 		– Sell
-8,183
Closed -$642K – 2720
2019
Q1 		$642K Buy
8,183
+3,497
+75% +$265K 0.01% 1476
2018
Q4 		$397K Sell
4,686
-24,659
-84% -$2.63M ﹤0.01% 1552
2018
Q3 		$5.03M Sell
29,345
-43,178
-60% -$6.51M 0.03% 526
2018
Q2 		$9.37M Buy
+72,523
New +$8.09M 0.05% 286
2017
Q3 		– Sell
-2,725
Closed -$206K – 2492
2017
Q2 		$206K Buy
+2,725
New +$191K ﹤0.01% 2031
2016
Q2 		– Sell
-3,527
Closed -$236K – 2297
2016
Q1 		$236K Buy
+3,527
New +$214K ﹤0.01% 1779
2015
Q4 		– Sell
-42,574
Closed -$2.27M – 2435
2015
Q3 		$2.27M Buy
42,574
+31,584
+287% +$1.92M 0.01% 833
2015
Q2 		$692K Buy
+10,990
New +$600K ﹤0.01% 1398
2014
Q2 		– Sell
-37,396
Closed -$1.57M – 2242
2014
Q1 		$1.57M Buy
+37,396
New +$1.56M 0.02% 713

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Jefferies Group's LGND Position: Q3 2021 in Review

Jefferies Group sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 37,621 shares — an estimated $3.08M sold.

Jefferies Group first reported a position in LGND in Q1 2014 and held it in 11 quarters. The position peaked at $9.37M in Q2 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Jefferies Group reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 37,621 Ligand Pharmaceuticals shares in Q3 2021, an estimated $3.08M.
  • Jefferies Group first reported a position in Ligand Pharmaceuticals in Q1 2014 and held it in 11 quarters.
  • Jefferies Group's Ligand Pharmaceuticals position peaked at $9.37M in Q2 2018.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.